Drug:
Reaction: THERAPY INTERRUPTED
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25138809 |
US |
62 | 2 |
Myasthenia gravis, Rash, Insurance issue, Therapy interrupted, |
||||
ROZANOLIXIZUMAB, |
||||
| 2 | 25139000 |
US |
||
Therapy interrupted, |
||||
BEVACIZUMAB-AWWB, BEVACIZUMAB-AWWB, |
||||
| 3 | 25139400 |
US |
||
Therapy interrupted, |
||||
BACLOFEN INJECTION, |
||||
| 4 | 25139417 |
US |
63 | 2 |
Therapy interrupted, |
||||
PEGFILGRASTIM, |
||||
| 5 | 25139776 |
US |
2 | |
Therapy interrupted, Product supply issue, |
||||
ERENUMAB-AOOE, |
||||
| 6 | 25139885 |
US |
81 | 2 |
Nasopharyngitis, Asthenia, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 7 | 25140022 |
US |
57 | 1 |
Pyrexia, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 8 | 25140035 |
US |
63 | 2 |
Hepatic enzyme increased, Therapy interrupted, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 9 | 25140313 |
JP |
80 | 2 |
Lower limb fracture, Spinal compression fracture, Therapy interrupted, |
||||
AMIKACIN, AMIKACIN, RIFAMPIN, CLARITHROMYCIN, |
||||
| 10 | 25140748 |
CA |
32 | 2 |
COVID-19, Drug ineffective, Influenza like illness, Small intestine ulcer, Therapy interrupted, Intentional dose omission, Incorrect dose administered, Product dose omission issue, Wrong technique in product usage process, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, ESZOPICLONE, LEVOTHYROXINE SODIUM, |
||||
| 11 | 25140878 |
US |
46 | 2 |
Drug dose omission by device, Device difficult to use, Therapy interrupted, Injection site injury, Psoriasis, |
||||
ETANERCEPT, LOSARTAN, VITAMIN E, CREAM, OIL, BIOTIN, HAIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 12 | 25141445 |
CA |
47 | 2 |
Illness, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 13 | 25142151 |
US |
68 | 2 |
Product distribution issue, Therapy interrupted, Pruritus, |
||||
POMALIDOMIDE, ACYCLOVIR, LOPERAMIDE HYDROCHLORIDE, GUAIFENESIN, PANTOPRAZOLE, RIVAROXABAN, |
||||
| 14 | 25142280 |
US |
||
Bone pain, Therapy interrupted, |
||||
BUROSUMAB, BUROSUMAB, BUROSUMAB, |
||||
| 15 | 25142849 |
US |
1 | |
Off label use, Therapy interrupted, |
||||
BEVACIZUMAB-AWWB, BEVACIZUMAB-AWWB, ATEZOLIZUMAB, |
||||
| 16 | 25145102 |
82 | 2 | |
Urinary tract infection, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 17 | 25145231 |
67 | 2 | |
Illness, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 18 | 25145233 |
70 | 2 | |
COVID-19, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 19 | 25145274 |
63 | 2 | |
Urinary tract infection, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 20 | 25145277 |
75 | 2 | |
Fungal infection, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 21 | 25145278 |
31 | 2 | |
Nasopharyngitis, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 22 | 25137581 |
US |
||
Psoriatic arthropathy, Dry eye, Gout, Osteoarthritis, Nodal osteoarthritis, Psoriasis, Therapy interrupted, Treatment failure, |
||||
INFLIXIMAB, APREMILAST, APREMILAST, ETANERCEPT, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, HYDROXYCHLOROQUINE, ADALIMUMAB, TOFACITINIB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, OIL, BIOTIN, HAIR, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LEFLUNOMIDE, DICLOFENAC SODIUM, LEFLUNOMIDE, |
||||
| 23 | 25137937 |
US |
61 | 1 |
Therapy interrupted, Product distribution issue, |
||||
LENALIDOMIDE, |
||||
| 24 | 25140920 |
57 | 2 | |
Illness, Therapy interrupted, |
||||
TOFACITINIB, |
||||
| 25 | 25132120 |
69 | 2 | |
Somnolence, Impaired driving ability, Therapy interrupted, Insurance issue, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, ROSUVASTATIN, |
||||
| 26 | 25132128 |
26 | 2 | |
Therapy partial responder, Product use issue, Therapy interrupted, Product availability issue, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, SOLRIAMFETOL, LEVOTHYROXINE, ESCITALOPRAM, ESCITALOPRAM, |
||||
| 27 | 25132130 |
57 | 1 | |
Dizziness, Product use issue, Therapy interrupted, |
||||
SOLRIAMFETOL, |
||||
| 28 | 25132140 |
|||
Adverse event, Therapy interrupted, Product availability issue, |
||||
SOLRIAMFETOL, |
||||
| 29 | 25132141 |
38 | ||
Malaise, Therapy interrupted, Insurance issue, |
||||
SOLRIAMFETOL, BELIMUMAB, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, |
||||
| 30 | 25132145 |
65 | 2 | |
Somnolence, Therapy interrupted, Insurance issue, |
||||
SOLRIAMFETOL, LEVOTHYROXINE SODIUM, |
||||
| 31 | 25132148 |
2 | ||
Fatigue, Therapy interrupted, Inability to afford medication, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, SOLRIAMFETOL, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, |
||||
| 32 | 25132467 |
US |
83 | 1 |
Device difficult to use, Therapy interrupted, Drug dose omission by device, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 33 | 25132604 |
CO |
54 | 1 |
Aphasia, Vomiting, Headache, Pyrexia, Disorientation, Off label use, Product dispensing issue, Therapy interrupted, |
||||
ROTIGOTINE, ROTIGOTINE, |
||||
| 34 | 25132858 |
2 | ||
Feeling abnormal, Therapy interrupted, Product availability issue, |
||||
SOLRIAMFETOL, |
||||
| 35 | 25132867 |
2 | ||
Asthenia, Product use issue, Therapy interrupted, |
||||
SOLRIAMFETOL, |
||||
| 36 | 25132873 |
68 | 2 | |
Somnolence, Sluggishness, Apathy, Brain fog, Memory impairment, Insurance issue, Therapy interrupted, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 37 | 25132951 |
US |
67 | 2 |
Thrombosis, Therapy interrupted, Product distribution issue, |
||||
APIXABAN, |
||||
| 38 | 25132984 |
US |
69 | 1 |
Surgery, Product use issue, Therapy interrupted, |
||||
TENAPANOR HYDROCHLORIDE, |
||||
| 39 | 25133659 |
40 | 2 | |
Psychotic disorder, Hunger, Feeling abnormal, Fatigue, Agoraphobia, Thinking abnormal, Somnolence, Dyspnoea, Anxiety, Panic attack, Product dose omission issue, Insurance issue, Therapy interrupted, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, |
||||
| 40 | 25133661 |
73 | 1 | |
Nasopharyngitis, Feeling abnormal, Product use issue, Product dose omission issue, Therapy interrupted, Overdose, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, SOLRIAMFETOL, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, FLUOXETINE HYDROCHLORIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, HYDROCHLOROTHIAZIDE, |
||||
| 41 | 25133670 |
75 | 1 | |
Pain, Lethargy, Withdrawal syndrome, Product use issue, Therapy interrupted, Product distribution issue, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, ARIPIPRAZOLE, MIRTAZAPINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ATORVASTATIN CALCIUM, LISINOPRIL, |
||||
| 42 | 25133677 |
2 | ||
COVID-19, Insurance issue, Therapy interrupted, |
||||
SOLRIAMFETOL, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, ATOMOXETINE HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 43 | 25133841 |
US |
2 | |
Toxicity to various agents, Cardiac failure, Hepatic failure, Renal failure, Systemic lupus erythematosus, Thrombosis, Respiratory failure, Bedridden, Cough, Productive cough, Aphonia, Aphonia, Therapy interrupted, |
||||
AMIKACIN, AMIKACIN, |
||||
| 44 | 25133872 |
US |
1 | |
Aneurysm, Peripheral artery bypass, Sepsis, Leg amputation, Headache, Therapy interrupted, |
||||
BRIVARACETAM, LEVETIRACETAM, |
||||
| 45 | 25134022 |
US |
1 | |
Loss of consciousness, Tremor, Restless legs syndrome, Therapy interrupted, Insurance issue, |
||||
ROTIGOTINE, |
||||
| 46 | 25134169 |
US |
||
Ascites, Pleural effusion, Blood urea nitrogen/creatinine ratio increased, Stomatitis, Oral discomfort, Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, FUROSEMIDE, FUROSEMIDE, ENZALUTAMIDE, |
||||
| 47 | 25134175 |
US |
||
Prostatectomy, Therapy interrupted, |
||||
RELUGOLIX, ALLOPURINOL, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BISOPROLOL FUMARATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), PREDNISONE, |
||||
| 48 | 25134930 |
62 | 2 | |
Therapy interrupted, Rash, |
||||
DENOSUMAB, |
||||
| 49 | 25134989 |
CO |
1 | |
Urocele, Inguinal hernia, Therapy interrupted, |
||||
METRELEPTIN, |
||||
| 50 | 25135199 |
CO |
||
Glycosylated haemoglobin increased, Diabetic metabolic decompensation, Portal hypertensive gastropathy, Varices oesophageal, Hydronephrosis, Bladder trabeculation, Dental caries, Transaminases increased, Product dispensing issue, Therapy interrupted, |
||||
MARALIXIBAT CHLORIDE, MARALIXIBAT CHLORIDE, MARALIXIBAT CHLORIDE, PHYTONADIONE, RIFAMPIN, URSODIOL, URSOSIOL, |
||||
| 51 | 25135612 |
US |
66 | 2 |
Rheumatoid arthritis, Insurance issue, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 52 | 25135632 |
2 | ||
Influenza, Therapy interrupted, |
||||
MACITENTAN, |
||||
| 53 | 25135679 |
60 | 1 | |
Influenza, Therapy interrupted, |
||||
TOFACITINIB, |
||||
| 54 | 25135687 |
1 | ||
Quality of life decreased, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 55 | 25136182 |
US |
58 | 2 |
Therapy interrupted, Insurance issue, |
||||
LENALIDOMIDE, |
||||
| 56 | 25136233 |
|||
Mania, Therapy interrupted, |
||||
| 57 | 25136268 |
US |
31 | 2 |
Therapy interrupted, Rebound psoriasis, Rash, |
||||
APREMILAST, IXEKIZUMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 58 | 25136531 |
IE |
1 | |
Cognitive disorder, Therapy interrupted, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 59 | 25136638 |
US |
62 | 2 |
Musculoskeletal stiffness, Insurance issue, Therapy interrupted, Joint swelling, Arthralgia, |
||||
ABATACEPT, ABATACEPT, |
||||
| 60 | 25140398 |
82 | 1 | |
Gastrointestinal haemorrhage, Therapy interrupted, Post procedural haemorrhage, |
||||
APIXABAN, |
||||
| 61 | 25140418 |
61 | 2 | |
Fracture, Therapy interrupted, |
||||
USTEKINUMAB, |
||||
| 62 | 25140464 |
60 | 2 | |
Influenza, Therapy interrupted, |
||||
TOFACITINIB, |
||||
| 63 | 25140466 |
47 | 2 | |
Breast cancer, Therapy interrupted, |
||||
SECUKINUMAB, |
||||
| 64 | 25140467 |
70 | 2 | |
Therapy interrupted, |
||||
SECUKINUMAB, |
||||
| 65 | 25140576 |
73 | 2 | |
Infection, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 66 | 25140784 |
63 | 2 | |
Sinusitis, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 67 | 25126340 |
US |
1 | |
Hernia, Chest pain, Cough, Therapy interrupted, |
||||
AMIKACIN, |
||||
| 68 | 25126426 |
US |
60 | 2 |
Therapy interrupted, Product supply issue, |
||||
LENALIDOMIDE, |
||||
| 69 | 25126531 |
AT |
54 | 2 |
Thrombocytopenia, Chest discomfort, Headache, Nausea, Therapy interrupted, |
||||
AMIKACIN, |
||||
| 70 | 25126543 |
US |
69 | 2 |
Rheumatoid arthritis, Tendonitis, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 71 | 25126697 |
FR |
84 | 2 |
Death, Lip haemorrhage, Rehabilitation therapy, Dysphonia, Aphonia, Therapy interrupted, |
||||
AMIKACIN, AMIKACIN, |
||||
| 72 | 25126878 |
US |
2 | |
Off label use, Product distribution issue, Therapy interrupted, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 73 | 25126904 |
US |
2 | |
Therapy interrupted, Insurance issue, |
||||
BIMEKIZUMAB, |
||||
| 74 | 25126979 |
US |
2 | |
Psoriasis, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 75 | 25127005 |
US |
1 | |
Therapy interrupted, Insurance issue, |
||||
BIMEKIZUMAB, |
||||
| 76 | 25127014 |
US |
2 | |
Insurance issue, Therapy interrupted, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 77 | 25127068 |
US |
2 | |
Therapy interrupted, Insurance issue, |
||||
BIMEKIZUMAB, |
||||
| 78 | 25127087 |
US |
||
Insurance issue, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 79 | 25127091 |
US |
2 | |
Psoriasis, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 80 | 25127129 |
US |
36 | 2 |
Hidradenitis, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 81 | 25127130 |
US |
2 | |
Alopecia, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 82 | 25127218 |
US |
2 | |
Psoriasis, Product availability issue, Therapy interrupted, |
||||
BIMEKIZUMAB, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, GABAPENTIN, BUSPIRONE HYDROCHLORIDE, AMOXICILLIN, PREDNISONE, |
||||
| 83 | 25127228 |
US |
39 | 2 |
Therapy interrupted, Product availability issue, |
||||
BIMEKIZUMAB, |
||||
| 84 | 25127236 |
US |
51 | 1 |
Road traffic accident, Therapy interrupted, Product availability issue, |
||||
BIMEKIZUMAB, |
||||
| 85 | 25127253 |
US |
1 | |
Psoriasis, Product availability issue, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 86 | 25127300 |
US |
2 | |
Hospitalisation, Atrial fibrillation, Dizziness, Therapy interrupted, Presyncope, Haemoptysis, |
||||
SELEXIPAG, AMBRISENTAN, |
||||
| 87 | 25127508 |
US |
||
Blood urine present, Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, RELUGOLIX, RELUGOLIX, ENZALUTAMIDE, |
||||
| 88 | 25127580 |
US |
2 | |
Hospitalisation, Therapy interrupted, Off label use, |
||||
AMIKACIN, AMIKACIN, |
||||
| 89 | 25127700 |
US |
1 | |
Rheumatoid arthritis, Crohn^s disease, Bronchitis, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, UPADACITINIB, |
||||
| 90 | 25127931 |
US |
80 | 1 |
Platelet count decreased, Product prescribing issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 91 | 25128002 |
US |
||
Neuropathy peripheral, Nocturia, Ear discomfort, Fall, Ligament sprain, Eructation, Vomiting, Fatigue, Asthenia, Therapy interrupted, Underdose, |
||||
OLAPARIB, |
||||
| 92 | 25128055 |
GB |
1 | |
Hospitalisation, Differential white blood cell count abnormal, Leukocytosis, Neutrophilia, Therapy interrupted, Intentional product misuse, |
||||
CLOZAPINE, |
||||
| 93 | 25128069 |
US |
74 | 1 |
Product supply issue, Therapy interrupted, Off label use, |
||||
LENALIDOMIDE, |
||||
| 94 | 25128129 |
US |
65 | 1 |
Neuropathy peripheral, Therapy interrupted, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 95 | 25128671 |
US |
||
Vulvovaginal rash, Vulvovaginal pain, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 96 | 25128922 |
US |
2 | |
Gastroenteritis viral, Therapy interrupted, |
||||
TROFINETIDE, |
||||
| 97 | 25128936 |
71 | 1 | |
Oesophagitis, Sepsis, Pneumonia, Vascular device infection, Therapy interrupted, Malignant neoplasm progression, |
||||
CARBOPLATIN, |
||||
| 98 | 25128937 |
2 | ||
Drug ineffective, Pain, Therapy interrupted, Infection, Illness, |
||||
ETANERCEPT, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CALCIUM CARBONATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 99 | 25128960 |
US |
71 | 2 |
Malaise, Therapy interrupted, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, PREDNISONE, SPIRONOLACTONE, FLUTICASONE FUROATE, MACITENTAN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ZOLPIDEM TARTRATE, NINTEDANIB, SERTRALINE HYDROCHLORIDE, LORAZEPAM, TADALAFIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BUSPIRONE HYDROCHLORIDE, OXYGEN, 0XYGEN, ALBUTEROL SULFATE, FUROSEMIDE, FERROUS SULFATE, |
||||
| 100 | 25128972 |
2 | ||
Drug ineffective, Pain, Malignant neoplasm progression, Therapy interrupted, |
||||
SELPERCATINIB, SELPERCATINIB, SELPERCATINIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28